Citations

Mayo Clinic

Showing 10 of 108551 citations.

Effect of Health Service Area on Primary Care Physician Provision of Low-Value Cancer Screening
Dindinger‐Hill, Kassandra , Horns, Joshua J. , Ambrose, Jacob , Vehawn, Jeffrey , Choudry, Mouneeb, Hunt, Trevor C. , Chipman, Jonathan , Haaland, Benjamin , Li, Jiaming , O’Neil, Brock , Li, Jiaming , Hanson, Heidi A.

Annals of Internal Medicine | April 22, 2024 | Volume: 177 | Issue: 5 | Pages: 583-591

10.7326/m23-1456 | PMID 38648640 Get It

Democratizing Artificial Intelligence in Anatomic Pathology
Flotte, Thomas J. , Derauf, Stephanie A., Byrd, Rachel K., Kroneman, Trynda, Bell, Debra A., Stetzik, Lucas, Lee, Seung‐Yi , Samiei, Alireza, García, Joaquín J. , Beamer, Gillian , Kroneman, Trynda N, Hart, Steven N. , Westerling-Bui, Thomas

Archives of Pathology & Laboratory Medicine | April 22, 2024 | Volume: 149 | Issue: 1 | Pages: 55-59

10.5858/arpa.2023-0205-oa | PMID 38649149 Get It

Context.— Artificial intelligence is a transforming technology for anatomic pathology. Involvement within the workforce will foster support for algorithm development and implementation. Objective.— To develop a supportive ecosystem that enables pathologists with variable expertise in artificial intelligence to create algorithms in a development environment with seamless transition to a production environment. Design.— Platform requirements included (1) approachable and intuitive user interface, (2) diverse algorithmic modeling options, (3) support capability for internal and external collaborations, (4) a seamless mechanism for discovery to clinical deployment transition, (5) the ability to meet minimum institutional requirements for information technology (IT) review, and (6) the ability to be scalable over time. The ecosystem required platform education, data science guidance, project management structure, and ongoing leadership. Results.— The development team considered internal development and vended solutions. Because of the extended timeline and resource requirements for internal development, a decision was made to use a vended solution. Vendor proposals were solicited and reviewed by pathologists, IT, and security groups. A vendor was selected and pipelines for development and production were established. Proposals for development were solicited from the pathology department. Eighty-four investigators were selected for the initial cohort, receiving training and access to dedicated subject matter experts. A total of 30 of 31 projects progressed through the model development process of annotating, training, and validation. Based on these projects, 15 abstracts were submitted to national meetings. Conclusions.— Democratizing artificial intelligence by creating an ecosystem to support pathologists with varying levels of expertise can break down entry barriers, reduce overall cost of algorithm development, improve algorithm quality, and enhance the speed of adoption.
Tiny Jellyfish Contribute to Elucidating Regeneration
Carmichael, Stephen W.

Microscopy Today | April 22, 2024 | Volume: 32 | Issue: 2 | Pages: 8-9

10.1093/mictod/qaae008 Get It

AAPM Task Group 334: A guidance document to using radiotherapy immobilization devices and accessories in an MR environment
Hobson, Maritza A. , Hu, Yanle , Glide‐Hurst, Carri , Jackson, Paul D., Jang, Sunyoung, Narayanan, Sreeram, Park, Justin C., Steffen, John J., Zhou, Yong , Caldwell, Barrett S. , Cohen, Gil’ad N. , Huang, Long , Jang, Sunyoung, Langner, Ulrich W. , Lee, Hannah J. , Levesque, Ives R. , Steffen, John, Wu, Qiuwen , Zhou, Yong

Medical Physics | April 22, 2024 | Volume: 51 | Issue: 6 | Pages: 3822-3849

10.1002/mp.17061 | PMID 38648857 Get It

AbstractUse of magnetic resonance (MR) imaging in radiation therapy has increased substantially in recent years as more radiotherapy centers are having MR simulators installed, requesting more time on clinical diagnostic MR systems, or even treating with combination MR linear accelerator (MR‐linac) systems. With this increased use, to ensure the most accurate integration of images into radiotherapy (RT), RT immobilization devices and accessories must be able to be used safely in the MR environment and produce minimal perturbations. The determination of the safety profile and considerations often falls to the medical physicist or other support staff members who at a minimum should be a Level 2 personnel as per the ACR. The purpose of this guidance document will be to help guide the user in making determinations on MR Safety labeling (i.e., MR Safe, Conditional, or Unsafe) including standard testing, and verification of image quality, when using RT immobilization devices and accessories in an MR environment.
Task-based automatic keV selection: leveraging routine virtual monoenergetic imaging for dose reduction on clinical photon-counting detector CT *
Rajendran, Kishore , Bruesewitz, Michael R. , Swicklik, Joseph R., Ferrero, Andrea , Thorne, Jamison E. , Yu, Lifeng , Bruesewitz, Michael, Swicklik, Joseph, Thorne, Jamison, McCollough, Cynthia, Rajendran, Kishore , Yu, Lifeng , McCollough, Cynthia H. , Leng, Shuai

Physics in Medicine & Biology | April 22, 2024 | Volume: 69 | Issue: 11 | Pages: 115029

10.1088/1361-6560/ad41b3 | PMID 38648795 Get It

Abstract Objective . Photon-counting detector (PCD) CT enables routine virtual-monoenergetic image (VMI) reconstruction. We evaluated the performance of an automatic VMI energy level (keV) selection tool on a clinical PCD-CT system in comparison to an automatic tube potential (kV) selection tool from an energy-integrating-detector (EID) CT system from the same manufacturer. Approach. Four torso-shaped phantoms (20–50 cm width) containing iodine (2, 5, and 10 mg cc −1 ) and calcium (100 mg cc −1 ) were scanned on PCD-CT and EID-CT. Dose optimization techniques, task-based VMI energy level and tube-potential selection on PCD-CT (CARE keV) and task-based tube potential selection on EID-CT (CARE kV), were enabled. CT numbers, image noise, and dose-normalized contrast-to-noise ratio (CNR d ) were compared. Main results . PCD-CT produced task-specific VMIs at 70, 65, 60, and 55 keV for non-contrast, bone, soft tissue with contrast, and vascular settings, respectively. A 120 kV tube potential was automatically selected on PCD-CT for all scans. In comparison, EID-CT used x-ray tube potentials from 80 to 150 kV based on imaging task and phantom size. PCD-CT achieved consistent dose reduction at 9%, 21% and 39% for bone, soft tissue with contrast, and vascular tasks relative to the non-contrast task, independent of phantom size. On EID-CT, dose reduction factor for contrast tasks relative to the non-contrast task ranged from a 65% decrease (vascular task, 70 kV, 20 cm phantom) to a 21% increase (soft tissue with contrast task, 150 kV, 50 cm phantom) due to size-specific tube potential adaptation. PCD-CT CNR d was equivalent to or higher than those of EID-CT for all tasks and phantom sizes, except for the vascular task with 20 cm phantom, where 70 kV EID-CT CNR d outperformed 55 keV PCD-CT images. Significance . PCD-CT produced more consistent CT numbers compared to EID-CT due to standardized VMI output, which greatly benefits standardization efforts and facilitates radiation dose reduction.
Spatially fractionated radiation therapy: a critical review on current status of clinical and preclinical studies and knowledge gaps
Prezado, Yolanda , Jouglar, Emmanuel , Martínez‐Rovira, Immaculada , Ortiz, Ramón , Chang, S , Grams, Michael, Ortiz, Ramon , Grams, Michael P. , Seco, Joao Carlos

Physics in Medicine & Biology | April 22, 2024 | Volume: 69 | Issue: 10 | Pages: 10TR02

10.1088/1361-6560/ad4192 | PMID 38648789 Get It

Abstract Spatially fractionated radiation therapy (SFRT) is a therapeutic approach with the potential to disrupt the classical paradigms of conventional radiation therapy. The high spatial dose modulation in SFRT activates distinct radiobiological mechanisms which lead to a remarkable increase in normal tissue tolerances. Several decades of clinical use and numerous preclinical experiments suggest that SFRT has the potential to increase the therapeutic index, especially in bulky and radioresistant tumors. To unleash the full potential of SFRT a deeper understanding of the underlying biology and its relationship with the complex dosimetry of SFRT is needed. This review provides a critical analysis of the field, discussing not only the main clinical and preclinical findings but also analyzing the main knowledge gaps in a holistic way.
Most Promising Approaches to Improve Brain AVM Management: ARISE I Consensus Recommendations
Samaniego, Edgar A. , Dabus, Guilherme , Meyers, Philip M. , Kan, Peter , Frösén, Juhana , Lanzino, Giuseppe , Welch, Babu G. , Gonzalez, L. Fernando , Fifi, Johanna T , Charbel, Fady T. , Khalessi, Alexander A. , Marks, Michael P. , Berenstein, Alejandro , Pereira, V Mendes, Bain, Mark, Narayanan, Sandra , Tateshima, Satoshi , Siddiqui, Adnan H. , Wakhloo, Ajay K. , Lawton, Michael T. , Kan, Peter , Volovici, Victor , Gonzalez, Fernando , Fifi, Johanna T , Hoh, Brian L , Berenstein, Alejandro , Colby, Geoffrey P , Narayanan, Sandra , Tateshima, Satoshi , Siddiqui, Adnan H , Wakhloo, Ajay K , Arthur, Adam Stephen , Lawton, Michael T , Samaniego, Edgar A , Lanzino, Giuseppe , Welch, Babu , Dabus, Guilherme C. , Volovici, Victor , Hoh, Brian L. , Colby, Geoffrey P.

Stroke | April 22, 2024 | Volume: 55 | Issue: 5 | Pages: 1449-1463

10.1161/strokeaha.124.046725 | PMID 38648282 Get It

Brain arteriovenous malformations (bAVMs) are complex, and rare arteriovenous shunts that present with a wide range of signs and symptoms, with intracerebral hemorrhage being the most severe. Despite prior societal position statements, there is no consensus on the management of these lesions. ARISE (Aneurysm/bAVM/cSDH Roundtable Discussion With Industry and Stroke Experts) was convened to discuss evidence-based approaches and enhance our understanding of these complex lesions. ARISE identified the need to develop scales to predict the risk of rupture of bAVMs, and the use of common data elements to perform prospective registries and clinical studies. Additionally, the group underscored the need for comprehensive patient management with specialized centers with expertise in cranial and spinal microsurgery, neurological endovascular surgery, and stereotactic radiosurgery. The collection of prospective multicenter data and gross specimens was deemed essential for improving bAVM characterization, genetic evaluation, and phenotyping. Finally, bAVMs should be managed within a multidisciplinary framework, with clinical studies and research conducted collaboratively across multiple centers, harnessing the collective expertise and centralization of resources.
Endoscopic Ultrasound-based Shear Wave Elastography for Detection of Advanced Liver Disease
Chin, Jerry Yung‐Lun , Kaur, Jyotroop, Law, Ryan , Garimella, Vishal, Levy, Michael J. , Dierkhising, Ross , Venkatesh, Sudhakar, AbiMansour, Jad P. , Vargas, Eric J. , Dayyeh, Barham K. Abu , Storm, Andrew C. , Allen, Alina M. , Venkatesh, Sudhakar K. , Chandrasekhara, Vinay

Journal of Clinical Gastroenterology | April 22, 2024 | Volume: 59 | Issue: 3 | Pages: 256-261

10.1097/mcg.0000000000002013 | PMID 38648501 Get It

Background and Aims: Endoscopic ultrasound shear wave elastography (EUS-SWE) is a novel modality for liver stiffness measurement. The aims of this study are to evaluate the performance and reliability of EUS-SWE for detecting advanced liver disease in a prospective cohort. Methods: EUS-SWE measurements were prospectively obtained from patients undergoing EUS between August 2020 and March 2023. Liver stiffness measurements were compared between patients with and without advanced liver disease (ALD), defined as stage ≥3, to determine diagnostic accuracy for advanced fibrosis and portal hypertension. Logistic regression was performed to identify variables that impact the reliability of EUS-SWE readings. Select patients underwent paired magnetic resonance elastography (MRE) for liver fibrosis correlation. Results: Patients with ALD demonstrated higher liver stiffness compared to healthy controls (left lobe: 17.6 vs. 12.7 kPa, P <0.001; median right lobe: 24.8 vs. 11.0 kPa, P <0.001). The area under the receiver operator characteristic (AUROC) for the detection of ALD was 0.73 and 0.80 for left and right lobe measurements, respectively. General anesthesia was associated with reliable EUS-SWE liver readings (odds ratio: 2.73, 95% CI: 1.07-7.39, P =0.040). Left lobe measurements correlated significantly with MRE with an increase of 0.11 kPa (95% CI: 0.05-0.17 kPA) for every 1 kPa increase on EUS-SWE. D. Conclusions: SWE is a promising technology that can readily be incorporated into standard EUS examinations for the assessment of ALD.
Rapid and Sensitive Detection of Fentanyl and Its Analogs by a Novel Chemiluminescence Immunoassay
Zhao, Jiangyang , Uddin, Mezbah, Unsihuay, Daisy , Butler, William E. , Xia, Terrance W., Xu, Jayson Z., Sheng, Xiaolin , Jannetto, Paul J. , Xia, Xiao‐Feng , Butler, William, Wang, Simon, Wang, Ping

Clinical Chemistry | April 22, 2024 | Volume: 70 | Issue: 7 | Pages: 978-986

10.1093/clinchem/hvae071 | PMID 38757262 Get It

Abstract Background Abuse of fentanyl and its analogs is a major contributor to the opioid overdose epidemic in the United States, but detecting and quantifying trace amounts of such drugs remains a challenge without resorting to sophisticated mass spectrometry-based methods. Methods A sensitive immunoassay with a sub-picogram limit of detection for fentanyl and a wide range of fentanyl analogs has been developed, using a novel high-affinity antibody fused with NanoLuc, a small-size luciferase that can emit strong and stable luminescence. When used with human urine samples, the assay has a sub-picogram limit of detection for fentanyl, with results fully concordant with LC-MS. Results When applied to clinical samples, the novel chemiluminescence immunoassay can detect low positive fentanyl missed by routine screening immunoassays, with a limit of detection of 0.8 pg/mL in human urine. When applied to environmental samples, the assay can detect levels as low as 0.25 pg fentanyl per inch2 of environment surface. Assay turnaround time is less than 1 h, with inexpensive equipment and the potential for high-throughput automation or in-field screening. Conclusions We have established a novel assay that may have broad applications in clinical, environmental, occupational, and forensic scenarios for detection of trace amounts of fentanyl and its analogs.
The Burden of Overweight and Obesity-Associated Gastrointestinal Cancers in Low and Lower-Middle-Income Countries: A Global Burden of Disease 2019 Analysis
Danpanichkul, Pojsakorn , Auttapracha, Thanida , Sukphutanan, Banthoon , Ng, Cheng Han , Wattanachayakul, Phuuwadith , Kongarin, Siwanart , Dutta, Priyata , Duangsonk, Kwanjit , Thongpiya, Jerapas , Seko, Yuya , Noureddin, Mazen , Yang, Ju Dong , Wallace, Michael B. , Muthiah, Mark D , Seko, Yuya , Takahashi, Hirokazu , Yang, Ju Dong , Wijarnpreecha, Karn , Wallace, Michael B , Ng, Cheng Han , Danpanichkul, Pojsakorn , Huang, Daniel Q. , Lui, Rashid , Wijarnpreecha, Karn

American Journal of Gastroenterology | April 22, 2024 | Volume: 119 | Issue: 6 | Pages: 1177-1180

10.14309/ajg.0000000000002819 | PMID 38900306 Get It

INTRODUCTION: Obesity is associated with cancer, including gastrointestinal (GI). Data from low (LICs) and lower-middle-income countries (MICs) are limited. METHODS: We utilized data from the Global Burden of Disease Study 2019 to determine the mortality from GI cancer risk of high body mass index (BMI) in these countries. RESULTS: Mortality rates of GI cancers from high BMI increased in LICs and lower MICs, while burdens decreased or remained stable in high and middle-income countries. DISCUSSION: The GI cancer-related burden from high BMI increased in LICs and lower MICs, necessitating a concerted effort to tackle the obesity pandemic.